Chemical injection device

The drug injection device with an encoder unit addresses the issue of inaccurate drug infusion by precisely measuring and preventing over- or under-infusion through rotation detection, ensuring safe and accurate drug delivery.

JP7583477B2Active Publication Date: 2024-11-14EOFLOE
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
JP2023515206
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-10-15
Filing Date
2021-09-07
Publication Date
2024-11-14
Estimated Expiration
2041-09-07

AI Technical Summary

Technical Problem

Existing drug injection devices lack accuracy in determining over- or under-infusion of drug solutions, posing risks for diabetic patients who require precise insulin administration.

Method used

A drug injection device equipped with an encoder unit that measures the rotation of a drive wheel to accurately calculate the injection amount, using contact patterns to detect normal operation and prevent over- or under-injection by monitoring the drive unit's rotation.

Benefits of technology

The device ensures precise measurement of drug delivery, reducing the risk of over- or under-infusion by accurately detecting the injection amount and providing real-time alerts for safe drug administration.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007583477000001
    Figure 0007583477000001
  • Figure 0007583477000002
    Figure 0007583477000002
  • Figure 0007583477000003
    Figure 0007583477000003
Patent Text Reader

Abstract

The present invention provides a drug solution injection device, comprising: a base; a needle assembly mounted on the base; a reservoir fluidly connected to the needle assembly and having a plunger therein; a drive unit for linearly moving the plunger; and an encoder unit disposed at an end of the drive unit for measuring rotation of the drive unit.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present disclosure relates to a medical fluid injection device. The present disclosure also provides a method, apparatus and computer program product for determining medical fluid over- or under-injection. [Background technology]

[0002] Diabetes is a metabolic disorder in which insulin secretion is insufficient or does not function normally, causing blood sugar levels outside the normal range. Diabetes is a complex disease that can affect various tissues of the human body, resulting in complications such as blindness, kidney failure, heart failure, and nerve damage, and the number of diabetes patients is said to be increasing every year.

[0003] In the case of diabetes, blood glucose must be monitored using a blood glucose meter and controlled by appropriate means such as diet, exercise programs, insulin injections, or oral antidiabetic drugs.

[0004] In recent years, there has been a demand for techniques to more accurately determine whether a drug solution has been over- or under-injected. Summary of the Invention [Problem to be solved by the invention]

[0005] The present disclosure provides a drug solution injection device that can be safely driven and deliver drugs accurately. Furthermore, the present disclosure provides a method, device, and computer program product for determining over-injection or under-injection of drug solution. The technical problem to be achieved by the present embodiment is not limited to the above technical problem, and other technical problems can be inferred from the following embodiments. [Means for solving the problem]

[0006] One aspect of the present invention provides a drug injection device that includes a base, a needle assembly mounted to the base, a reservoir fluidly connected to the needle assembly and having a plunger therein, a drive unit that moves the plunger linearly, and an encoder unit disposed at an end of the drive unit that measures the rotation of the drive unit. Effect of the Invention

[0007] The liquid injection device according to an embodiment of the present invention can check whether the device is operating normally and can measure the amount of liquid medicine stored in the reservoir. The encoder unit can accurately measure data related to the rotation of the drive wheel to detect whether the liquid injection device is operating normally. In addition, the encoder unit can measure the rotation angle of the drive wheel to calculate the moving distance of the plunger, so that the amount of liquid medicine injected into the user by the liquid injection device can be measured.

[0008] In the liquid injection device according to an embodiment of the present invention, the encoder unit can accurately detect the rotation of the drive wheel. Since a step is disposed between the drive wheel and the tooth step, the encoder unit is accurately electrically connected or electrically shorted by the step. The encoder unit can accurately measure the electrical connection / short circuit, accurately measure the rotation angle of the drive wheel, and accurately measure the amount of liquid injected.

[0009] The liquid injector according to one embodiment of the present invention can reduce the control load by using data measured by the encoder unit. The rotation angle of the drive wheel is calculated based on the ON / OFF signal measured by the encoder unit, and the rotation angle of the drive wheel, the moving distance of the plunger, the amount of liquid injected, etc. can be quickly calculated. Of course, the scope of the present invention is not limited to such effects.

[0010] According to the means for solving the problems of the present disclosure described above, over- or under-injection of chemical solution can be determined more accurately by determining the number of times the contact pattern before the change to the encoder unit is confirmed.

[0011] In addition, the number of times the contact pattern is checked before the change is accumulated and stored in a buffer until the number of times the contact pattern is changed reaches a preset number or more, and over-injection or under-injection of the drug solution is determined based on the accumulated number of confirmations stored in the buffer, thereby making it possible to more accurately determine over-injection or under-injection. [Brief description of the drawings]

[0012] [Figure 1] 1 is a block diagram showing a chemical liquid injection system according to an embodiment of the present invention; [Diagram 2] 1 is a perspective view showing a chemical liquid injector according to an embodiment of the present invention; [Diagram 3] FIG. 3 is an exploded perspective view of the liquid injector of FIG. 2. [Figure 4] FIG. 4 is a perspective view showing a partial configuration of FIG. 3. [Diagram 5] FIG. 5 is a perspective view showing one side of FIG. [Figure 6] FIG. 13 is a plan view showing the actuation for sensing the flow rate of the reservoir; [Figure 7] FIG. 13 is a plan view showing the actuation for sensing the flow rate of the reservoir; [Figure 8] 6 is a cross-sectional view showing a cross section of an end portion of the drive unit of FIG. 5. FIG. [Figure 9] 3 is a block diagram showing a partial configuration of the liquid injector shown in FIG. 2. [Figure 10] 11 is a cross-sectional view showing an actuation for injecting a liquid medicine into a reservoir, storing the liquid medicine, and discharging the liquid medicine into a needle. FIG. [Figure 11] 11 is a cross-sectional view showing an actuation for injecting a liquid medicine into a reservoir, storing the liquid medicine, and discharging the liquid medicine into a needle. FIG. [Figure 12] 11 is a cross-sectional view showing an actuation for injecting a liquid medicine into a reservoir, storing the liquid medicine, and discharging the liquid medicine into a needle. FIG. [Figure 13] 11 is a cross-sectional view showing an actuation for injecting a liquid medicine into a reservoir, storing the liquid medicine, and discharging the liquid medicine into a needle. FIG. [Figure 14] 11 is a graph showing a change in the amount of liquid medicine and a change in the drive mode due to driving of the liquid injector. [Figure 15] 4 is a graph showing signal detection of an encoder unit. [Figure 16] 11 is a flow chart illustrating a method for determining over- or under-injection of a medical fluid when a contact pattern is changed, according to one embodiment. [Figure 17] 11 is a flow chart illustrating a method for determining over- or under-injection of a medical fluid during one revolution of a drive wheel according to one embodiment. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0013] (Best Mode for Carrying Out the Invention) As a technical means for achieving the above-mentioned technical objectives, one aspect of the present invention provides a drug injection device including a base, a needle assembly attached to the base, a reservoir fluidly connected to the needle assembly and having a plunger therein, a drive unit for linearly moving the plunger, and an encoder unit disposed at an end of the drive unit for measuring the rotation of the drive unit.

[0014] The encoder unit may also include a base cover attached to an end of the drive unit and rotating together with the drive unit, a first contact end connected to contact one side of the base cover, and a second contact end arranged on the other side of the base cover and selectively contacting the base cover in response to rotation of the drive unit.

[0015] The base cover may also include a cover stage extending in a circumferential direction of the rotating drive unit, and a plurality of tooth stages extending from the cover stage but spaced apart from each other along the circumferential direction of the cover stage.

[0016] The drive unit may further include a protruding step disposed between adjacent tooth steps, and the protruding step and the tooth steps may have a step in a circumferential direction.

[0017] The first contact end and the second contact end may be elastic.

[0018] Another aspect of the present invention can provide a drug injection device that includes a base, a needle assembly mounted to the base, a reservoir fluidly connected to the needle assembly and having a plunger therein, a drive unit that moves the plunger linearly, an encoder unit disposed at an end of the drive unit that detects rotation of the drive unit, and a control module that determines over-injection or under-injection of drug based on the rotation of the drive unit detected by the encoder unit.

[0019] Another aspect of the present invention can provide a method for determining over- or under-injection of a medicinal solution, the method including the steps of determining that a current contact pattern for an encoder unit is a first contact pattern based on detection of rotation of a drive unit by an encoder unit, checking whether the current contact pattern is maintained as the first contact pattern and calculating a number of confirmations, obtaining the number of confirmations of the first contact pattern in response to a change of the current contact pattern from the first contact pattern to a second contact pattern, and determining over- or under-injection of a medicinal solution based on the number of confirmations.

[0020] Another aspect of the present invention may provide a computer program product including one or more computer-readable recording media having stored thereon a program that performs the following steps: determining that a current contact pattern for an encoder unit is a first contact pattern based on detection of rotation of a drive unit by an encoder unit; checking whether the current contact pattern is maintained as the first contact pattern and calculating a number of confirmations; acquiring the number of confirmations of the first contact pattern in response to a change of the current contact pattern from the first contact pattern to a second contact pattern; and determining over-injection or under-injection of a medicinal solution based on the number of confirmations.

[0021] (Mode for carrying out the invention) Hereinafter, with reference to the accompanying drawings, an embodiment of the present invention will be described in detail so that a person having ordinary skill in the art to which the present invention belongs can easily carry out the present invention. However, the present invention may be implemented in various different forms and is not limited to the embodiments described herein. In addition, in order to clearly explain the present invention in the drawings, parts that are not related to the description are omitted, and similar parts are designated by similar reference numerals throughout the specification.

[0022] Throughout this specification, when a part is described as being "connected" to another part, this includes not only when the part is "directly connected" to another part, but also when the part is "electrically connected" to another part via another element therebetween. Furthermore, when a part is described as "including" a certain component, this does not mean that the part excludes the other component, but that the part may further include the other component, unless otherwise specified.

[0023] The present disclosure will now be described in detail with reference to the accompanying drawings.

[0024] FIG. 1 is a block diagram showing a chemical liquid injection system 1 according to an embodiment of the present invention.

[0025] 1, a liquid injection system 1 may include a liquid injector 10, a user terminal 20, a controller 30, and a biological information sensor 40. The liquid injection system 1 allows a user to drive and control the system using the user terminal 20, and allows a liquid to be periodically injected from the liquid injector 10 based on blood glucose information monitored by the biological information sensor 40.

[0026] The drug injection device 10 may also perform the function of injecting drugs to be injected into the user, such as insulin, glucagon, anesthetics, painkillers, dopamine, growth hormones, smoking cessation aids, etc., based on data detected by the bioinformation sensor 40.

[0027] Furthermore, the liquid injector 10 can send device status messages to the controller 30, including information on the remaining battery level of the device, whether the device has been started up, whether the injection has been completed, etc. The messages sent to the controller can be sent to the user terminal 20 via the controller 30. Alternatively, the controller 30 can send improved data obtained by processing the received messages to the user terminal 20.

[0028] In one embodiment, the liquid injector 10 may be provided separately from the biological information sensor 40 and installed away from the subject. In another embodiment, the liquid injector 10 and the biological information sensor 40 may be provided in a single device.

[0029] In one embodiment, the liquid medicine injection device 10 may be worn on the body of a user, or in another embodiment, the liquid medicine injection device 10 may be worn on an animal to inject a liquid medicine.

[0030] The user terminal 20 can receive an input signal from a user in order to drive and control the liquid injection system 1. The user terminal 20 can generate a signal for driving the controller 30 and control the controller 30 to drive the liquid injector 10. The user terminal 20 can also display biological information measured by the biological information sensor 40, and can display status information of the liquid injector 10.

[0031] The user terminal 20 means a communication terminal that can be used in a wired or wireless communication environment. For example, the user terminal 20 may be a smartphone, a tablet PC, a PC, a smart TV, a mobile phone, a PDA (personal digital assistant), a laptop, a media player, a microserver, a GPS (global positioning system) device, an e-book reader, a digital broadcasting terminal, a navigation system, a kiosk, an MP3 player, a digital camera, a home appliance, a device with a camera, and other mobile or non-mobile computing devices. The user terminal 20 may also be a wearable device such as a watch, glasses, a headband, or a ring that has a communication function and a data processing function. However, as described above, any terminal equipped with an application capable of Internet communication can be used without restrictions.

[0032] The user terminal 20 may be connected one-to-one to a pre-registered controller 30. The user terminal 20 may be connected to the controller 30 in an encrypted manner to prevent the controller 30 from being driven and controlled by an external device.

[0033] In one embodiment, the user terminal 20 and the controller 30 may be separated and provided as separate devices. For example, the controller 30 may be provided to a subject wearing the liquid injector 10, and the user terminal 20 may be provided to the subject or a third party. The safety of the liquid injection system 1 can be improved by operating the user terminal 20 by a guardian.

[0034] In another embodiment, the user terminal 20 and the controller 30 may be provided as a single device. The controller 30 provided integrally with the user terminal 20 can communicate with the liquid injector 10 to control the injection of the drug.

[0035] The controller 30 functions to transmit and receive data to and from the liquid injector 10, and can transmit control signals to the liquid injector 10 regarding the injection of drugs such as insulin, and receive control signals from the bioinformation sensor 40 regarding the measurement of biometric values ​​such as blood glucose.

[0036] As an example, the controller 30 can send an instruction request to the liquid injector 10 to measure the current state of the user, and receive measurement data from the liquid injector 10 in response to the instruction request.

[0037] The bioinformation sensor 40 can perform a function of measuring biometric values ​​such as the user's blood glucose level, blood pressure, and heart rate depending on the purpose. Data measured by the bioinformation sensor 40 is sent to the controller 30, and the drug cycle and / or injection amount can be set based on the measured data. Data measured by the bioinformation sensor 40 may be sent to the user terminal 20 and displayed.

[0038] As an example, the biological information sensor 40 may be a sensor that measures the blood glucose level of a subject. It may be a Continuous Glucose Monitoring (CGM) sensor. A continuous glucose monitoring sensor is attached to a subject and can continuously monitor the blood glucose level.

[0039] The user terminal 20, the controller 30, and the liquid injector 10 can communicate with each other using a network. For example, the network includes a local area network (LAN), a wide area network (WAN), a value-added network (VAL), a mobile radio communication network, a satellite communication network, and a combination thereof, and is a comprehensive data communication network that enables each network component to smoothly communicate with each other, and may include wired Internet, wireless Internet, and a mobile wireless communication network. In addition, examples of wireless communication include, but are not limited to, wireless LAN (Wi-Fi), Bluetooth (Bluetooth, a registered trademark), Bluetooth low energy, ZigBee, Wi-Fi Direct (WFD), ultra wideband wireless communication (UWB), infrared data association (IrDA), near field communication (NFC), and 5G.

[0040] FIG. 2 is a perspective view showing a chemical liquid injection device 10 according to one embodiment of the present invention, FIG. 3 is an exploded perspective view of the chemical liquid injection device 10 of FIG. 2, FIG. 4 is a perspective view showing a partial configuration of FIG. 3, and FIG. 5 is a perspective view showing one side of FIG. 4.

[0041] 2 to 5, the liquid injector 10 is attached to a user who injects a liquid medicine, and can inject a fixed amount of liquid medicine stored inside the device into the user's body at a preset amount.

[0042] The liquid medicine injector 10 can be used for various purposes depending on the type of liquid medicine to be injected. For example, the liquid medicine may include an insulin-based liquid medicine for diabetic patients, a liquid medicine for the pancreas, a liquid medicine for the heart, and various other types of liquid medicine.

[0043] One embodiment of the liquid injection device 10 may include a housing 11 that covers the outside, and an attachment portion 12 that is positioned adjacent to the user's skin. The liquid injection device 10 includes a number of components that are disposed in an internal space between the housing 11 and the attachment portion 12. Another connecting means may be further interposed between the attachment portion 12 and the user's skin, and the liquid injection device 10 may be fixed to the skin by the connecting means.

[0044] The liquid injection device 10 may include a needle assembly 100, a reservoir unit 200, a drive module 300, a battery 350, a drive unit 400, a clutch unit 500, a trigger member 600, a needle cover assembly 700, an alarm unit 800, and a plurality of sensor units.

[0045] In the liquid injection device 10, at least one body serving as a base may form a frame that supports the internal components. The base may have a first body 13, a second body 14, and a third body 15 depending on the arrangement.

[0046] The first body 13 is disposed under the housing 11, and can support the needle assembly 100, the reservoir unit 200, the driving module 300, the battery 350, etc. in each opening or groove. The second body 14 is disposed under the first body 13, and can be connected to the mounting part 12. The second body 14 can cover the lower part of the drug solution injector 10. The third body 15 is disposed above the first body 13, and can support the reservoir unit 200, the driving module 300, the battery 350, the driving unit 400, etc. in each opening or groove. Although the first body 13, the second body 14, and the third body 15 are shown in the drawings, the present invention is not limited thereto, and they may be formed as one body or as a plurality of bodies.

[0047] A control module 16 may be disposed inside the liquid injector 10. The control module 16, which is a circuit board, is disposed under the second body 14 and can control the overall operation of the liquid injector 10. The control module 16 is in electrical contact with the drive module 300, the battery 350, the alarm unit 800, and the multiple sensor units and can control their operation.

[0048] The needle assembly 100 can be attached to the first body 13. The needle assembly 100 can move the needle N and / or the cannula axially by rotation of the sleeve 110.

[0049] One end of the needle N can be connected to the reservoir unit 200 to deliver the medicinal liquid, and the other end can be inserted into the cannula and moved along the cannula.

[0050] The cannula has a conduit shape capable of receiving the needle N, so that the medicinal liquid discharged from the needle N can be injected into the user.

[0051] The cannula remains inserted into the user's skin, but the needle N rises and is separated from the subject. However, the cannula and the needle N form a path for fluid to travel, and the medicinal liquid injected from the reservoir 210 can be injected into the user through the needle N and the cannula.

[0052] The drug injection device 10 allows a user to simply rotate the needle assembly 100 to insert the cannula into the subject and begin drug injection.

[0053] The reservoir unit 200 is attached to the first body 13 and the third body 15, and is connected to the needle assembly 100. The reservoir unit 200 stores a medicinal liquid D in an internal space, and can transfer a fixed amount of the medicinal liquid to the needle N in response to the movement of the plunger 230. The reservoir unit 200 can include a reservoir 210, a cap cover 220, a plunger 230, a seal ring 240, and a connector member 250 (see FIG. 6).

[0054] The reservoir 210 extends to a preset length in the longitudinal direction and can store a medicinal liquid in its internal space. The reservoir 210 can eject the medicinal liquid into the needle N by moving the plunger 230. A cap cover 220 is attached to the end of the reservoir 210, and the rod 410 and / or the connecting member 520 can move through an opening (not shown) arranged in the cap cover 220 (see FIG. 10).

[0055] The reservoir 210 may have an inlet end and an outlet end, the inlet end being for injecting a medicinal solution, and the outlet end being provided with a needle N through which the medicinal solution can be discharged.

[0056] The plunger 230 is disposed inside the reservoir 210, and can move linearly by being driven by the driving module 300 and the driving unit 400. As the plunger 230 advances, the medicinal liquid can be discharged from the internal space into the needle N.

[0057] The plunger 230 may have an end 231 and an inclined surface 232. The end 231 may move toward the front 210F of the reservoir 210 to move the drug solution. The inclined surface 232 may come into close contact with the inclined portion of the reservoir 210.

[0058] The plunger 230 can be connected to a rearwardly extending connector member 250. The connector member 250 is mounted to the plunger 230 and can move linearly therewith in response to linear movement of the plunger 230.

[0059] The connector member 250 may be made of a conductive material and have a shaft shape. The connector member 250 moves and comes into contact with the first sensor unit 910A, thereby making it possible to measure the amount of stored drug or to start driving the liquid injector 10.

[0060] The connector member 250 is connected to the rear end of the plunger 230 and can move together with the plunger 230 in response to the movement of the plunger 230. In the drawings, the connector member 250 is shown to have a saft shape, but is not limited thereto, and may have various shapes that contact the first sensor unit 910A to generate an electrical signal.

[0061] When the medicinal liquid is stored in the reservoir 210 and the plunger 230 retracts, the connector member 250 can retract together with the plunger 230. Also, when the plunger 230 advances so that the medicinal liquid is discharged from the reservoir 210 into the needle N, the connector member 250 can advance together with the plunger 230.

[0062] The plunger 230 is provided with a seal ring 240 at a portion that contacts the inner wall of the reservoir 210, and can prevent leakage of the medicinal liquid when the plunger 230 moves.

[0063] The driving module 300 can generate a driving force and transmit the driving force to the driving unit 400. The driving force transmitted by the driving unit 400 can move the plunger 230 linearly into the reservoir 210 to discharge the liquid medicine.

[0064] When the drive units 400 are engaged with each other by the clutch unit 500, the drive module 300 rotates the drive wheel 420 of the drive unit 400, which in turn causes linear movement of the rod 410, which in turn causes movement of the plunger 230. As the plunger 230 moves, the connector member 250 can also move linearly.

[0065] Any type of device having a liquid suction force and a liquid discharge force by electricity may be used as the driving module 300. For example, any type of pump, such as a mechanical displacement micropump or an electromagnetic motion micropump, may be used. The mechanical displacement micropump is a pump that uses the movement of a solid or fluid, such as a gear or a diaphragm, to generate a pressure difference to induce a fluid flow, and includes a positive displacement diaphragm pump, a positive displacement fluid pump, and a rotary pump. The electromagnetic motion micropump is a pump that uses electrical or magnetic energy directly to move a fluid, and includes an electrohydrodynamic pump (EHD), an electroosmotic pump, a magnetohydrodynamic pump, an electrowetting pump, and the like.

[0066] The battery 350 can supply electricity to the liquid injector 10 and activate each component. Although a pair of batteries 350 is shown in the drawing, the present invention is not limited to this and various settings can be made depending on the capacity, range of use, duration of use, etc. of the liquid injector 10.

[0067] The battery 350 is disposed adjacent to the driving unit 400 and can supply electricity to the driving unit 400. The battery 350 is also connected to the control module 16 and can measure data related to the number of rotations or rotation speed of the driving unit 400, the amount of medicinal liquid stored in the reservoir 210, the amount of medicinal liquid injected into the user, etc., based on the electrical signal measured by the sensor unit.

[0068] 10, the driving unit 400 is provided between the driving module 300 and the reservoir unit 200, and can move the plunger 230 disposed in the reservoir 210 by the driving force generated by the driving module 300. However, the driving unit 400 can move the plunger 230 forward only when the rod 410 and the driving wheel 420 are coupled or connected by the clutch unit 500.

[0069] The rod 410 is connected to the plunger 230 and extends in one direction. The rod 410 is inserted into an opening in the cap cover 220, and the rod 410 can move in the longitudinal direction of the reservoir 210 to move the plunger 230. The rod 410 may have a thread shape on its surface. The rod 410 is inserted into the connecting member 520, and when the drug solution is dispensed in a fixed amount, the rod 410 is connected to the driving wheel 420 by the clutch unit 500, and the rod 410 can move forward.

[0070] The driving wheel 420 is drivingly connected to the driving module 300 and can be rotated by the driving of the driving module 300. The driving wheel 420 has a first connecting end 421 and a second connecting end 422, and can have a space inside in which the rod 410 can move. At least one of the first connecting end 421 and the second connecting end 422 is always drivingly connected to the driving module 300 by the connector CN, so that the driving wheel 420 can be rotated by the driving of the driving module 300.

[0071] In one embodiment, the first connecting end 421 and the second connecting end 422 may have a gear tooth shape, and the connector CN connected to the driving module 300 can apply force to the gear teeth to rotate the driving wheel 420.

[0072] In detail, the connector CN repeatedly rotates about the rotation axis in response to the linear reciprocating motion of the drive module 300. An end of the connector CN can apply a force to at least one of the first connection end 421 and the second connection end 422 to rotate the drive wheel 420. For example, one end of the connector CN can be arranged to apply a force to the first connection end 421, and the other end of the connector CN can be arranged to apply a force to the second connection end 422.

[0073] When the connector CN rotates around the rotation axis, the second sensor unit 920 can measure the movement of the connector CN. The second sensor unit 920 can measure whether or not there is contact with the connector CN, and can measure whether the driving force of the driving module 300 is transmitted to the driving wheel 420. In addition, the second sensor unit 920 can measure the rotation angle of the driving wheel 420 by measuring whether or not there is contact with the connector CN.

[0074] The clutch unit 500 may drivingly connect the drive module 300 and the drive unit 400. The clutch unit 500 is disposed between the rod 410 and the drive wheel 420 and may include a coupler 510 and a connecting member 520.

[0075] The coupler 510 is disposed outside the connection member 520 and is spaced apart from the connection member 520 at a predetermined distance when inactive (FIGS. 10 and 11), and can connect the rod 410 and the driving wheel 420 when active (FIGS. 12 and 13). The coupler 510 is a part that can apply a force to the outside of the connection member 520 with an elastic force, and is not limited to a specific shape. However, for the sake of convenience, the following description will be centered on the case where the coupler is in the form of a spring.

[0076] The connecting member 520 can be arranged so that at least a portion of it is inserted into the rod 410. The connecting member 520 is arranged so as to cover the outside of the rod 410. The connecting member 520 can connect the driving module 300 and the rod 410 in response to the operation of the coupler 510.

[0077] In one embodiment, the rod 410 and the connecting member 520 may have a screw and a thread form, respectively. The rod 410 may have a thread formed on an outer circumferential surface thereof, and the connecting member 520 may have a thread formed on an inner circumferential surface thereof, so that they may be connected in a screw-threaded form.

[0078] In one embodiment, the connecting member 520 may be threaded on one end and unthreaded on the other end.

[0079] 10, a screw thread is formed on the inner circumferential surface of the first section L1 of the connecting member 520, and only the first section L1 is screwed into the rod 410. In addition, the diameter of the first section L1 corresponds to the rod 410 and may have a size of D1.

[0080] The second section L2 of the connecting member 520 does not have a thread formed on the inner peripheral surface. The diameter D2 of the second section L2 can be set to be larger than the diameter D1 of the first section L1. In the second section L2, the connecting member 520 does not come into contact with the rod 410.

[0081] The length of the first section L1 can be set so that the connecting member 520 overlaps with the coupler 510 when the connecting member 520 moves rearward. With reference to Figures 11 and 12, when the plunger 230 extends rearward, at least a portion of the first section L1 is disposed so as to overlap with the coupler 510, i.e., so that at least a portion faces the coupler 510. The length of the first section L1 can be set by the connecting member 520 so that the coupler 510 grips at least a portion of the first section L1 when the coupler 510 is activated.

[0082] Since the rod 410 is screwed only at the first section L1 of the connecting member 520, when the connecting member 520 rotates to move the rod 410 forward, the load caused by the screwing between the connecting member 520 and the rod 410 can be reduced.

[0083] 12 and 13, when the coupler 510 is activated, the coupler 510 grips the connecting member 520, and the connecting member 520 rotates together with the rotation of the drive wheel 420. Since the connecting member 520 and the rod 410 are screwed together only in the first section L1, the connecting member 520 can move the rod 410 forward even when the drive wheel 420 rotates with a small torque. That is, since the rod 410 and the connecting member 520 are screwed together only in the first section L1, the plunger 230 can move forward by the drive of the drive unit 400 even with a somewhat weak force.

[0084] The trigger member 600 can generate a mechanical signal to inject a medicinal liquid from the medicinal liquid injector 10. The trigger member 600 is rotatably disposed on one side of the third body 15, and the trigger member 600 rotates to start driving the driving module 300, and at the same time, the clutch unit 500 can drive and connect the driving unit 400.

[0085] The trigger member 600 can rotate in one direction around the rotation axis. At this time, the trigger member 600 can apply force to the clutch unit 500 to couple the rod and the drive wheel 420 together.

[0086] In particular, when a user rotates the needle assembly 100, the knob of the needle assembly 100 can apply force to an end of the trigger member 600 to initiate rotation of the trigger member 600. As the trigger member 600 rotates, the trigger member 600 applies force to an end of the coupler 510, causing the coupler 510 to engage with the connecting member 520 and activating the clutch unit 500.

[0087] The needle cover assembly 700 can be attached under the needle assembly 100. The needle cover assembly 700 can prime the air stored in the reservoir unit 200 before injecting the medicinal liquid. When the medicinal liquid is injected into the reservoir 210 through the medicinal liquid injector NI, the gas (air) remaining in the reservoir 210 can be discharged to the outside.

[0088] The needle cover assembly 700 can include a first cover 710 , a second cover 720 , a filter member 730 , and an adhesive layer 740 .

[0089] First cover 710 can be disposed at the bottom of medical solution injector 10. Second cover 720 can be inserted into the opening of first cover 710 and assembled. An insertion protrusion 711 that is inserted into second body 14 to fix needle cover assembly 700 can be disposed on one side of first cover 710.

[0090] The second cover 720 is assembled to the first cover 710, and the needle N and / or the cannula may be aligned in the center. The second cover 720 may have a storage space penetrating the center in the height direction in which the medicinal solution D is stored.

[0091] The first cover 710 has higher rigidity than the second cover 720. The first cover 710 is a portion exposed to the outside, and is made of a material having a somewhat higher rigidity. The second cover 720 is assembled to the first cover 710 and inserted into the opening of the third body 15, and is made of a material having a lower rigidity than the first cover 710.

[0092] The second cover 720 may have a protrusion 721 at the center thereof, which is inserted into the third body 15. The second cover 720 may also have a fixing protrusion 722, which may be inserted into the first cover 710, thereby assembling the first cover 710 and the second cover 720 together.

[0093] The filter member 730 is attached to the second cover 720. The filter member 730 is disposed under the storage space of the second cover 720, and gas such as air passes through the filter member 730, but liquid such as a medicinal solution does not pass through the filter member 730. Therefore, air discharged from the needle N passes through the filter member 730 and is discharged to the outside, but the medicinal solution discharged from the needle can be stored in the storage space defined by the second cover 720 and the filter member 730.

[0094] The shape of the filter member 730 may change depending on the amount of medicinal liquid stored in the storage space. For example, when the storage space is filled with medicinal liquid, the filter member 730 expands downward, allowing the user to recognize that the medicinal liquid has flowed into the needle cover assembly 700.

[0095] The adhesive layer 740 is disposed on one side of the needle cover assembly 700 and enables the needle cover assembly 700 to be attached to the mounting portion 12 .

[0096] The alarm unit 800 is disposed inside or outside the liquid injector 10 and can notify the user of normal or malfunction of the liquid injector 10 .

[0097] As an example, the alarm unit 800 is disposed under the housing 11 and connected to the circuit board. The alarm unit 800 can generate an alarm sound or generate a light to communicate an alarm to an external user.

[0098] 6 and 7 are plan views showing a drive for detecting the flow rate of the reservoir 210, FIG. 8 is a block diagram showing a partial configuration of the liquid injector 10 of FIG. 2, and FIG. 9 is a block diagram showing a partial configuration of the liquid injector 10 of FIG. 2.

[0099] 4 to 9, the plurality of sensor units can measure the operation of the liquid injector 10. The plurality of sensor units can measure the amount of liquid stored in the reservoir 210, whether the driving module 300 is driven, whether the driving unit 400 is driven, the rotation angle of the driving wheel 420, the moving distance of the plunger 230, etc.

[0100] Each sensor unit may have multiple contact tips that can measure the presence or absence of electrical contact to measure a respective event or data.

[0101] The position of either end of the contact end can be changed by contact with another component, and when the contact with the other component is released, the contact end can return to its original position by a restoring force.

[0102] In one embodiment, the contact end can have the form of an elastic spring. The contact end has a first end 900A that is connected to the control module 16, which is a circuit board, and a second end 900B that can contact the connector member 250 that extends from the first end 900A.

[0103] The diameter of the first end 900A can be set to be larger than the diameter of the second end 900B. Since the diameter of the first end 900A is formed to be larger than the diameter of the second end 900B, the first end 900A can be firmly supported on the circuit board. The first end 900A is stably supported on the control module 160, and the second end 900B can easily change its position or shape and stably maintain contact with other components.

[0104] The length of the first end 900A can be set to be shorter than the length of the second end 900B. Since the length of the first end 900A is shorter than the length of the second end 900B, the first end 900A can be firmly supported on the circuit board. The first end 900A is stably supported on the control module 160, and the second end 900B can easily change position and shape and stably maintain contact with other components.

[0105] In particular, since the diameter of the second end 900B is smaller than the diameter of the first end 900A, or the length of the second end 900B is set longer than the length of the first end 900A, even if the second end 900B comes into contact with other components such as the connector member 250 or the base cover 933, the position or shape of the second end 900B can easily be deformed, and the second end 900B can stably maintain contact with the other components.

[0106] The first sensor unit 910A is disposed adjacent to the reservoir unit 200. The first sensor unit 910A can be disposed on a moving path of the connector member 250. The first sensor unit 910A can have a plurality of contact ends, and the plurality of contact ends can be attached to the fixing groove 14A of the second body 14. The connector member 250 can come into contact with at least one or more of the plurality of contact ends while moving.

[0107] In one embodiment, the first sensor unit 910A may include a first contact end 911 and a second contact end 912. The first contact end 911 and the second contact end 912 are spaced apart from each other, and the connector member 250 may move linearly to contact the first contact end 911 and / or the second contact end 912.

[0108] The connector member 250 can contact the first contact end 911 at a first position P1 and the second contact end 912 at a second position P2.

[0109] 6, 10 and 11, during the process of injecting medicinal solution D into reservoir 210, connector member 250 first contacts first contact end 911 at first position P1 (plunger 230 is at P-1 position), and then connector member 250 contacts second contact end 912 at second position P2 (plunger 230 is at P-2 position).

[0110] In one embodiment, the connector member 250 can electrically connect the first contact end 911 and the second contact end 912. When the first contact end 911 and the second contact end 912 are electrically connected via the connector member 250, the control module 16 can recognize a particular event of the reservoir unit 200.

[0111] For example, when the connector member 250 contacts the first contact end 911 and the second contact end 912, the first sensor unit 910A can detect that the medicinal liquid stored in the reservoir 210 is stored at a first reference amount (for example, 10%, 20%, 30%, etc.).

[0112] When the control module 16 recognizes that the liquid medicine D has been stored in the reservoir 210 by the set first reference amount, the control module 16 can wake up the liquid medicine injector 10. That is, the control module 16 confirms that a certain amount of liquid medicine has been stored in the reservoir 210, and can start a part of the drive to preheat the liquid medicine injector 10 (first mode).

[0113] In other embodiments, the connector member 250 can contact at least one of the contact ends of the first sensor unit 910A to generate an electrical signal. When the connector member 250 contacts the first contact end 911, the control module 16 can recognize this as a first event, and when the connector member 250 contacts the second contact end 912, the control module 16 can recognize this as a second event.

[0114] For example, the connector member 250 can raise the liquid injector 10 by contacting the first contact end 911, and can detect the amount of liquid stored in the liquid injector 10 by contacting the second contact end 912.

[0115] For example, the connector member 250 can contact the first contact end 911 to raise the drug solution injection device 10 and thereby primarily detect the amount of drug solution stored in the reservoir 210, and can contact the second contact end 912 to secondarily detect the amount of drug solution stored in the drug solution injection device 10.

[0116] As shown in Figures 6, 12 and 13, during the process of discharging the medicinal solution D into the needle N, the connector member 250 first releases contact with the second contact end 912 at the second position P2 (the plunger 230 is at the P-2 position), and then the connector member 250 releases contact with the first contact end 911 at the first position P1 (the plunger 230 is at the P-1 position).

[0117] In one embodiment, the connector member 250 maintains contact between the first contact end 911 and the second contact end 912, and when the second contact end 912 separates from the contact, the electrical connection between the first contact end 911 and the second contact end 912 is released. When the electrical connection between the first contact end 911 and the second contact end 912 is released, the control module 16 can recognize this as a particular event of the reservoir unit 200.

[0118] In detail, when the second contact end 912 is separated, the control module 16 may generate a signal that the amount of medicinal liquid D stored in the reservoir 210 is not sufficient. The control module 16 may generate an alarm signal and transmit the alarm signal to the controller 30, the user terminal 20 and / or the alarm unit 800 so that the user can be aware of the amount of medicinal liquid.

[0119] In addition, when the third mode is set in the drug solution injection device 10, the second sensor unit 920 and / or the encoder unit 930 can be used to accurately measure the forward distance of the plunger 230 within the reservoir 210, and the amount of drug solution stored inside the reservoir 210 can be precisely measured and monitored.

[0120] In other embodiments, the connector member 250 can release contact with at least one of the contact ends of the first sensor unit 910A to recognize different events. When the connector member 250 releases contact with the second contact end 912, the control module 16 can recognize a third event, and when the connector member 250 releases contact with the second contact end 912, the control module 16 can recognize a fourth event.

[0121] For example, when the connector member 250 releases contact with the second contact end 912, the control module 16 can transmit an alarm signal to the user, and when the connector member 250 releases contact with the first contact end 911, the control module 16 can forcefully shut down the liquid injector 10, generate an alarm signal subsequently to the user terminal 20, reduce the amount of liquid injected to the user, or extend the injection period.

[0122] As shown in FIG. 6, the first sensor unit 910A may be disposed so that the surface of the contact end is in contact with the surface of the connector member 250, although it is spaced apart from the center line CL of the connector member 250 in the longitudinal direction.

[0123] The connector member 250 extends with respect to the center line CL and moves linearly along the center line CL. The outer peripheral surface of the connector member 250 is spaced apart from the center line CL by a distance t1. The centers of the contact ends are spaced apart from the center line CL by a distance t2, and the surfaces of the contact ends are spaced apart from the center line CL by a distance t3.

[0124] Since the magnitude of t1 is set to be greater than the magnitude of t3, when the connector member 250 moves rearward along the center line CL, it can come into contact with the first contact end 911 at point P1 and come into contact with the second contact end 912 at point P2. Also, when the connector member 250 moves forward along the center line CL, it can be released from contact with the second contact end 912 at point P2 and released from contact with the first contact end 911 at point P1.

[0125] The second sensor unit 920 can detect whether the driving module 300 and / or the driving unit 400 are driven. The driving module 300 and the driving wheel 420 are drivingly connected by a connector CN. When the driving module 300 moves linearly, the connector repeatedly rotates around a rotation axis, and both ends of the connector CN alternately apply force to the first connection end 421 and the second connection end 422 of the driving wheel 420, causing the driving wheel 420 to rotate. The second sensor unit 920 can measure whether the connector CN rotates around the rotation axis and the number of rotations.

[0126] The second sensor unit 920 can have a first A contact end 921 and a second A contact end 922. When the connector CN contacts the first A contact end 921, the second sensor unit 920 measures that the connector CN applies force to either the first connection end 421 or the second connection end 422. When the connector CN contacts the second A contact end 922, the second sensor unit 920 measures that the connector CN applies force to the other of the first connection end 421 and the second connection end 422.

[0127] The encoder unit 930 is disposed at one end of the drive unit 400 and is capable of measuring the rotation of the drive unit 400. The encoder unit 930 is capable of measuring the rotation of the drive wheel 420.

[0128] The encoder unit 930 may have a first B contact end 931, a second B contact end 932, and a base cover 933 having a cover step 933A and a tooth step 933B.

[0129] The first B contact end 931 is disposed at an end of the base cover 933 and can always maintain contact with the base cover 933. The first B contact end 931 can maintain contact with the cover step 933A.

[0130] Although the drawings show that the 1B contact end 931 is disposed on the opposite side to the 2B contact end 932, this is not limiting. For example, the 1B contact end 931 and the 2B contact end 932 may be disposed on the same side of the drive wheel 420. Also, the 1B contact end 931 may be disposed behind the drive wheel 420.

[0131] The second B contact end 932 is disposed at an end of the base cover 933 and spaced apart from the first B contact end 931. The second B contact end 932 is disposed to contact the tooth step 933B and can be brought into contact or released from contact according to the rotation of the drive wheel 420.

[0132] The base cover 933 is inserted into one end of the drive wheel 420. The cover step 933A extends around the outer circumferential surface of the drive wheel 420, while the tooth step 933B extends from the cover step 933A, but may be spaced apart along the outer circumferential surface of the drive wheel 420. The tooth step 933B may extend along the longitudinal direction of the drive wheel 420 from the cover step 933A.

[0133] In one embodiment, the width W1 of the tooth step 933B may be set to be smaller than the distance W2 between adjacent tooth steps. Since the width W1 is set to be smaller than the width W2, the second B contact end 932 can reduce an error generated when contacting the tooth step 933B.

[0134] 8, the tooth step 933B can be inserted into a space between the protruding steps 420P of the drive wheel 420. The protruding steps 420P are made of a non-conductive material, and the tooth step 933B is made of a conductive material, so that when the second B contact end 932 contacts the protruding step 420P, the first B contact end 931 and the second B contact end 932 are not electrically connected, but when the second B contact end 932 contacts the tooth step 933B, the first B contact end 931 and the second B contact end 932 can be electrically connected.

[0135] The protruding step 420P has a first wall 420P-1 and a second wall 420P-2, which form a boundary with the tooth step 933B. In response to the rotation of the connector CN, the drive wheel 420 moves counterclockwise as in FIG.

[0136] The protruding step 420P may have a height in the radial direction that varies along the circumferential direction of the drive wheel 420. The height of the protruding step 420P may be defined as the distance from the bottom surface of the tooth step 933B to the outer circumferential surface in the radial direction. Since the height of the protruding step 420P varies in the circumferential direction of the drive wheel 420, the tooth step 933B and the protruding step 420P may form a step.

[0137] As an example, the height of the first wall 420P-1 may be defined as r1, and the height of the second wall 420P-2 may be defined as r2, where r1 may be set to be smaller than r2.

[0138] As an example, the height r1 of the first wall 420P-1 can be set smaller than the height T of the tooth step 933B, and the height r2 of the second wall 420P-2 can be set larger than the height T of the tooth step 933B.

[0139] As an example, the height of the protruding step 420P may gradually increase from the first wall 420P-1 to the second wall 420P-2.

[0140] As an example, the first wall 420P-1 is disposed radially below the outermost angle line of the cover step 933A, and the second wall 420P-2 is disposed radially above the outermost angle line of the cover step 933A. Thus, a portion of the protruding step 420P is disposed below the outermost angle line of the cover step 933A, and another portion is disposed above the outermost angle line of the cover step 933A.

[0141] When the drive wheel 420 rotates, when the second B contact end 932 contacts the tooth step 933B, the second B contact end 932 contacts the tooth step 933B at a fixed position. However, when the second B contact end 932 contacts the protruding step 420P, the second B contact end 932 contacts the protruding step 420P while changing the contact position.

[0142] When the drive wheel 420 rotates, the position of the second B contact end 932 changes due to the step between the tooth step 933B and the protruding step 420P when the second B contact end 932 passes the boundary between the tooth step 933B and the protruding step 420P.

[0143] In detail, when the 2nd B contact end 932 passes through the first wall 420P-1 at the tooth step 933B, the step j1 causes a position change and impact on the 2nd B contact end 932. When the 2nd B contact end 932 passes through the tooth step 933B at the second wall 420P-2, the step j2 causes a position change and impact on the 2nd B contact end 932.

[0144] When the second B contact end 932 contacts the tooth step 933B, the first B contact end 931 and the second B contact end 932 are electrically connected, and the encoder unit 930 detects an electrical connection signal. When the driving wheel 420 further rotates and the second B contact end 932 contacts the protruding step 420P, the second B contact end 932 is electrically separated. The encoder unit 930 can measure the presence or absence of electrical connection and separation between the first B contact end 931 and the second B contact end 932 and the number of electrical connections, and measure the rotation angle and rotation speed of the driving wheel 420.

[0145] In order to improve the detection accuracy of the encoder unit 930, the second B contact end 932 must be accurately electrically shorted when it moves from the tooth stage 933B to the first wall 420P-1, and the second B contact end 932 must be accurately electrically connected when it moves from the second wall 420P-2 to the tooth stage 933B.

[0146] When the 2B contact end 932 passes through the step j1 and / or j2 between the protruding step 420P and the tooth step 933B, the position of the 2B contact end 932 changes abruptly, so that the 2B contact end 932 is accurately electrically short-circuited or connected, thereby improving the accuracy of the encoder unit 930.

[0147] 10 to 13 are cross-sectional views showing the drive for injecting the liquid medicine into the reservoir 210, storing the liquid medicine, and discharging the liquid medicine into the needle N, and FIG. 14 is a graph showing the change in the amount of liquid medicine and the change in drive mode due to the drive of the liquid injector 10.

[0148] 10 to 14, the process of storing medicinal liquid D in reservoir 210 before attaching medicinal liquid injection device 10 to a user, and then ejecting medicinal liquid D from reservoir 210 into needle N to inject medicinal liquid D into the user will be described as follows.

[0149] <Drug storage step> A user injects a liquid medicine into reservoir unit 200 of liquid medicine injector 10 using an external liquid medicine injector (not shown). As shown in Fig. 10, before the liquid medicine is injected, plunger 230 is placed at the front end of reservoir 210, and rod 410 is attached to connecting member 520 at the rear end of plunger 230. At this time, coupler 510 does not grip connecting member 520, so drive wheel 420 is not connected to rod 410.

[0150] A user puts a liquid medicine D to be injected into a liquid medicine injector (not shown) and inserts the liquid medicine injector into the inlet end of the reservoir unit 200. At this time, air remaining inside the reservoir 210 may be primed.

[0151] Specifically, during the assembly process of the reservoir unit 200, air remains between the reservoir 210 and the plunger 230. If a medicinal liquid is injected while air remains in the reservoir 210, there is a risk that the air will also be injected into the user, so an operation to remove the air (priming operation) is required.

[0152] When the medicinal liquid starts to flow from the medicinal liquid injector into the reservoir 210, the gas remaining between the inner surface of the reservoir 210 and the plunger 230 is pushed out to the needle N. At this time, the gas can move along the guide groove 211. That is, the gas remaining inside the reservoir 210 can be discharged to the needle N by the inflowing medicinal liquid D following the guide of the guide groove 211. The gas that has passed through the needle N moves to the needle cover assembly 700 and passes through the filter member 730 of the needle cover assembly 700 to be discharged to the outside. Due to the guide of the guide groove 211, the gas remaining inside the reservoir 210 is quickly discharged to the outside, and the gas in the reservoir 210 can be removed.

[0153] The first sensor unit 910A can be driven according to the amount of the liquid medicine D injected into the reservoir 210.

[0154] When the plunger 230 passes point P-1 in response to the injection of the medicinal liquid D, the connector member 250 comes into contact with the first contact end 911 at the first position P1. Then, when the plunger 230 passes point P-2, the connector member 250 comes into contact with the second contact end 912 at the second position P2.

[0155] In one embodiment, when the connector member 250 electrically connects the first contact end 911 and the second contact end 912, the first mode is activated. The first mode is a mode for waking up the liquid injection device 10, and the liquid injection device 10 can be preheated in advance so that it can be immediately activated when the liquid injection device 10 is attached to a user thereafter. In addition, the user can be notified via the user terminal 20 or the like that a preset first reference amount of the liquid D has been stored in the reservoir 210, and the user can be notified in advance to use the liquid injection device 10.

[0156] In another embodiment, when the connector member 250 is connected to the first contact end 911, the control module 16 may recognize a first event, and when the connector member 250 is connected to the second contact end 912, the control module 16 may recognize a second event. That is, when the connector member 250 is in contact with each of the different contact ends, different events may be recognized and the events may be communicated to the user.

[0157] <Installation steps> 11 , when the liquid medicine D is stored in the reservoir 210, the liquid medicine injection device 10 is attached to the user. Since the gas in the reservoir 210 is removed through the needle cover assembly 700 during the drug storage stage described above (completion of the priming operation), the needle cover assembly 700 is removed from the liquid medicine injection device 10.

[0158] The user attaches the drug solution injection device 10 to the user and rotates the needle assembly 100 to insert the needle N and the cannula into the skin. The needle N is inserted into the skin together with the cannula, and the insertion of the cannula into the skin can be guided.

[0159] The needle N is then withdrawn from the skin but remains connected to the cannula. As the user further rotates the needle assembly 100, the needle N moves upward with the cannula still inserted into the skin. The cannula and the needle N are at least partially connected to form and maintain a pathway for the medical fluid to travel.

[0160] <Drug injection step - 2nd mode> Substantially simultaneously with the operation of inserting the cannula and the needle N into the user, the driving module 300 and the driving unit 400 are driven. In the second mode, the medical solution injection device 10 can inject the medical solution D into the user according to the set period and injection amount.

[0161] When the user rotates the needle assembly 100 to insert the needle N and the cannula into the skin, the trigger member 600 drives the drive module 300. When the drive module 300 is driven, the connector CN rotates about the rotation axis to rotate the drive wheel 420. The connector CN can rotate the drive wheel 420 in units of one tooth while alternately applying force to the first connection end 421 and the second connection end 422.

[0162] When the user rotates the needle assembly 100, the trigger member 600 can activate the coupler 510 as shown in Figure 12. When the coupler 510 grips the outside of the connecting member 520, the drive wheel 420, the coupler 510 and the connecting member 520 are integrated into one body. Therefore, when the drive wheel 420 rotates, the connecting member 520 also rotates, and the rod 410 moves forward.

[0163] When the rod 410 moves forward, the plunger 230 also moves forward, discharging the drug solution into the needle N. Therefore, the drug can be injected into the user according to the set drive cycle and drive speed of the drive module 300.

[0164] At this time, the second sensor unit 920 can measure the rotation of the connector CN. The first A contact end 921 and the second A contact end 922 of the second sensor unit 920 alternately contact the corresponding ends of the connector CN. The second sensor unit 920 detects contact between the first A contact end 921 and one end of the connector CN, and detects contact between the second A contact end 922 and the other end of the connector CN.

[0165] In one embodiment, when the contact end of the second sensor unit 920 and the connector CN come into contact, the second sensor unit 920 can detect an electrical signal. In another embodiment, when the contact end of the second sensor unit 920 and the connector CN come into contact, the second sensor unit 920 can detect an impact signal due to an impact.

[0166] The second sensor unit 920 can measure whether the driving module 300 and the connector CN are driven based on data measuring the rotation of the connector, measure whether the driving wheel 420 is driven by the connector CN, measure the rotation angle and / or rotation speed of the driving wheel 420, and measure the movement distance of the plunger 230 and the amount of medicinal liquid injected by the rotation of the driving wheel 420.

[0167] When the drive wheel 420 rotates, the encoder unit 930 can measure the rotation angle, rotation speed, etc. of the drive wheel 420. The first B contact end 931 maintains electrical contact with the cover stage 933A, while the second B contact end 932 maintains electrical contact with the tooth stage 933B, but the electrical contact may be released when leaving the tooth stage 933B.

[0168] The encoder unit 930 can measure an electrically connected signal and / or an electrically released signal to measure data related to the rotation of the drive wheel 420. The control module 16 can calculate the rotation angle and rotation speed of the drive wheel 420 based on the data measured by the encoder unit 930, and can calculate the moving distance of the plunger 230 and the discharge amount of the medicinal liquid based on this.

[0169] <Drug injection step - 3rd mode> When the plunger 230 is in the P-2 position and the connector member 250 is in the second position P2, the first contact end 911 and the second contact end 912 of the first sensor unit 910A are electrically separated. The control module 16 can activate the third mode when the first sensor unit 910A is electrically disconnected.

[0170] In the third mode, the control module 16 may transmit an alarm signal to the user via the user terminal 20, the controller 30, and / or the alarm unit 800 that the amount of the stored liquid medicine corresponds to the second reference amount. The second reference amount may be defined as the amount of the liquid medicine recognized by the driving module 300 at the time of driving in the third mode. The control module 16 informs the user that the amount of the liquid medicine remaining in the reservoir 210 is the preset second reference amount, and the user may prepare to replace the liquid medicine injection device 10.

[0171] In one embodiment, the first reference amount may be set to the same drug solution storage amount as the second reference amount. Since the position of the plunger 230 in the reservoir 210 is the same when the plunger 230 moves forward or backward and the connector member 250 contacts or releases contact with the second contact end 912, the first reference amount and the second reference amount can be set to be the same.

[0172] In another embodiment, the first reference amount may be set to a liquid medicine storage amount greater than the second reference amount. The first reference amount is a reference value set for driving in the first mode, and may be set to be substantially equal to the amount of liquid medicine stored in the reservoir 210. The second reference amount is an amount of liquid medicine recognized by the driving module 300 at the start of the third mode, and may be set to be less than the amount of liquid medicine actually remaining in the reservoir 210 with a margin.

[0173] Since the second reference amount is set to be less than the actual amount of liquid medicine stored in the reservoir 210, the actual reservoir 210 has a margin corresponding to the difference between the actual remaining amount of liquid medicine and the second reference amount. Even if the liquid medicine injector 10 notifies the user that there is no liquid medicine left, the liquid medicine remaining in the reservoir 210 can be further used, thereby preventing sudden liquid medicine interruption or accidents and improving the safety of the liquid medicine injector 10.

[0174] Since the remaining amount of medicinal liquid is important in the third mode, the control module 16 can calculate the injection amount of medicinal liquid and the remaining amount of medicinal liquid in the reservoir 210 very precisely in the third mode. In the third mode, the control module 16 accurately measures the rotation angle of the drive wheel 420 and the movement distance of the plunger 230 based on the dates acquired by the second sensor unit 920 and the encoder unit 930, and can precisely calculate the discharge amount of medicinal liquid and the amount of medicinal liquid remaining in the reservoir 210. The remaining amount of medicinal liquid accurately calculated in the third mode is transmitted to the user in real time, allowing the user to recognize danger.

[0175] In one embodiment, the liquid medicine injector 10 can accurately count the amount of liquid medicine remaining in the reservoir 210 only in the third mode. In the second mode, the amount of liquid medicine stored in the reservoir 210 exceeds a preset range (i.e., a second reference amount), so the amount of liquid medicine in the reservoir 210 is not counted precisely, but in the third mode, the amount of liquid medicine stored in the reservoir 210 can be quantitatively counted. The amount of liquid medicine stored in the liquid medicine injector 10 is precisely counted only when an alarm is required, so that the control load of the liquid medicine injector 10 can be reduced.

[0176] FIG. 15 is a graph showing signal detection of the encoder unit 930. As shown in FIG.

[0177] 8 and 15, the encoder unit 930 can measure the electrical connection signal to measure data such as the rotation angle and rotation speed of the drive wheel 420.

[0178] Based on the data measured by the encoder unit 930, the control module 16 can accurately calculate the amount of medicinal liquid stored in the reservoir 210 and the amount of medicinal liquid injected into the user.

[0179] Since the electrical connection of the encoder unit 930 is turned ON / OFF, the rotation angle of the drive wheel 420 can be measured based on the point (i) when it is ON and / or the point (j) when it is OFF, thereby reducing the load on the control module 16.

[0180] Specifically, the control module 16 can determine a contact pattern for the encoder unit 930. Referring to Fig. 5, the encoder unit 930 can have a first B contact end 931, a second B contact end 932, and a base cover 933 having a cover step 933A and a tooth step 933B. The first B contact end 931 is disposed at an end of the base cover 933 and can constantly maintain contact with the base cover 933. The first B contact end 931 can maintain contact with the cover step 933A.

[0181] The second B contact end 932 is disposed at an end of the base cover 933 and spaced apart from the first B contact end 931. The second B contact end 932 is disposed to contact the tooth step 933B and can be brought into contact or released from contact according to the rotation of the drive wheel 420.

[0182] In one embodiment, when the first B contact end 931 maintains contact with the cover step 933A of the base cover 933 and the second B contact end 932 contacts the tooth step 933B of the base cover 933, the control module 16 can determine the current contact pattern as the first contact pattern. The first contact pattern is a state in which the first B contact end 931 and the second B contact end 932 are electrically connected, and at this time, the control module 16 can receive a high signal.

[0183] Also, when the second B contact end 932 is released from contact with the tooth step 933B of the base cover 933 while the first B contact end 931 maintains contact with the cover step 933A of the base cover 933, the control module 16 can determine the current contact pattern as the second contact pattern. The second contact pattern is a state in which the first B contact end 931 and the second B contact end 932 are not electrically connected, and in this case, the control module 16 can receive a low signal.

[0184] 8, the tooth step 933B may be inserted into a space between the protruding steps 420P of the drive wheel 420. The protruding steps 420P are made of a non-conductive material, and the tooth step 933B is made of a conductive material, so that when the second B contact end 932 contacts the protruding step 420P, the first B contact end 931 and the second B contact end 932 are not electrically connected, but when the second B contact end 932 contacts the tooth step 933B, the first B contact end 931 and the second B contact end 932 may be electrically connected.

[0185] Referring to FIG. 15, when the contact pattern is changed from the second contact pattern to the first contact, it corresponds to an ON time (i) at which the electrical connection is turned on, and when the contact pattern is changed from the first contact pattern to the second contact, it corresponds to an OFF time (j) at which the electrical connection is turned off.

[0186] The control module 16 may check whether the current contact pattern is maintained as the first contact pattern or the second contact pattern, and may calculate the number of checks. Specifically, the control module 16 may apply a current to the encoder unit 930 and receive a high or low signal every time the teeth of the drive wheel 420 move once.

[0187] When the first B contact end 931 and the second B contact end 932 are electrically connected, the control module 16 can receive a high signal. When the first B contact end 931 and the second B contact end 932 are not electrically connected, the control module 16 can receive a low signal. When a high signal is received, the control module 16 can determine that the current touch pattern is the first touch pattern, and when a low signal is received, the control module 16 can determine that the current touch pattern is the second touch pattern.

[0188] For example, the teeth of the drive wheel 420 move 100 times for the drive wheel 420 to rotate once, and four of each of the protruding step 420P and the tooth step 933B may be alternately positioned around the drive wheel 420. In this case, when the drive wheel 420 rotates once, the contact pattern changes eight times. That is, one contact pattern corresponds to 12.5 tooth movements. In this case, if the number of confirmations for one contact pattern exceeds 13 times, it indicates that the drive wheel 420 has rotated less than intended, which corresponds to a situation in which the drug solution has been underinjected. As another example, if another contact pattern is confirmed in a situation in which the number of confirmations for one contact pattern is less than 12 times, it indicates that the drive wheel 420 has rotated more than intended, which corresponds to a situation in which the drug solution has been overinjected.

[0189] A method for determining whether the drug solution has been underinjected or overinjected will be specifically described below.

[0190] FIG. 16 is a flow chart illustrating a method for determining over- or under-injection of a medical fluid when a contact pattern is changed according to one embodiment.

[0191] 16, in step 1610, H, L, and C are all set to 0 (zero). H indicates the number of times the first touch pattern has been confirmed, L indicates the number of times the second touch pattern has been confirmed, and C indicates a rating value used to determine over- or under-injection.

[0192] In step 1620, the drive module 300 may be driven.

[0193] When the driving module 300 is driven, the medicinal liquid stored in the reservoir 210 is discharged to the outside through the medicinal liquid injector NI. When the driving module 300 is driven once, the teeth of the driving wheel 420 of the driving unit 400 connected to the driving module 300 move once.

[0194] In step 1630, the control module 16 may determine the current touch pattern.

[0195] The control module 16 can apply a current to the encoder unit 930 and receive a high or low signal each time a tooth of the drive wheel 420 moves once. If a high signal is received, the control module 16 can determine that the current touch pattern is the first touch pattern, and if a low signal is received, the control module 16 can determine that the current touch pattern is the second touch pattern.

[0196] When the second B contact end 932 comes into contact with the tooth stage 933B of the base cover 933 while the first B contact end 931 maintains contact with the cover stage 933A of the base cover 933, the control module 16 can determine the current contact pattern as the first contact pattern. Also, when the second B contact end 932 releases from contact with the tooth stage 933B of the base cover 933 while the first B contact end 931 maintains contact with the cover stage 933A of the base cover 933, the control module 16 can determine the current contact pattern as the second contact pattern.

[0197] If the current touch pattern is the first touch pattern, proceed to step 1640. However, if the current touch pattern is the second touch pattern, proceed to step 1650.

[0198] In step 1640, control module 16 may determine whether the current touch pattern has changed from a first touch pattern to a second touch pattern.

[0199] That is, since L indicates the number of times the second contact pattern has been confirmed, an L value greater than 0 means that the second B contact end 932 has been released from contact with the toothed portion 933 B of the base cover 933 .

[0200] If the first touch pattern is not changed to the second touch pattern and the first touch pattern is maintained, ie, if the L value is 0, the process proceeds to step 1641 .

[0201] In step 1620, the drive module 300 is driven and the first contact pattern is still maintained after the teeth of the drive wheel 420 of the drive unit 400 have moved once, so when the control module 16 applies current to the encoder unit 930, a high signal is received.

[0202] In step 1641, in response to receiving a high signal, control module 16 may increase the number of confirmations of the first touch pattern, i.e., the H value, by 1. Control module 16 maintains the L value at 0.

[0203] After step 1641, the process returns to step 1620 again.

[0204] On the other hand, if the current touch pattern was changed from the first touch pattern to the second touch pattern, step 1640 proceeds to step 1642 .

[0205] In step 1642, the control module 16 may assign the H value, which is the number of confirmations of the first contact pattern, to the C value, which is an evaluation value used to determine over- or under-injection.

[0206] The control module 16 can determine over- or under-injection based on the C value. For example, if the teeth of the drive wheel 420 move 100 times for one rotation of the drive wheel 420, and the contact pattern changes 8 times when the drive wheel 420 rotates, the contact pattern corresponds to 12.5 tooth movements. If the C value is more than 13 times, the control module 16 can determine that the medical solution has been under-injected. Alternatively, if the C value is less than 12 times, the control module 16 can determine that the medical solution has been over-injected.

[0207] Although not shown in FIG. 16, if an over-injection or under-injection is determined, the control module 16 can stop operation of the liquid injection device 10 or notify the user of an alarm to guide them to stop operation of the liquid injection device 10.

[0208] If neither over-injection nor under-injection occurs, proceed to step 1643 .

[0209] In step 1643, control module 16 may reset the number of confirmations H of the first touch pattern to zero and set the number of confirmations L of the second touch pattern to one.

[0210] After step 1643, the process returns to step 1620 again.

[0211] Returning again to step 1630, if the current touch pattern is the second touch pattern, proceed to step 1650.

[0212] In step 1650, control module 16 may determine whether the current touch pattern has changed from the second touch pattern to the first touch pattern.

[0213] That is, since H represents the number of times the first contact pattern has been confirmed, an H value greater than 0 means that the second B contact end 932 has come into contact with the tooth step 933 B of the base cover 933 .

[0214] If the first contact pattern has been changed to the second contact pattern, ie, if the H value is 0, proceed to step 1651 .

[0215] In step 1620, the drive module 300 is driven and the second contact pattern is still maintained after the teeth of the drive wheel 420 have moved once, so when the control module 16 applies current to the encoder unit 930, a low signal is received.

[0216] In step 1651, in response to receiving a low signal, the control module 16 may increase the number of confirmations of the second touch pattern, i.e., the L value, by 1. The control module 16 maintains the H value at 0.

[0217] After step 1651, the process returns to step 1620 again.

[0218] On the other hand, if the current touch pattern was changed from the second touch pattern to the first touch pattern, step 1650 proceeds to step 1652 .

[0219] In step 1652, the control module 16 may assign the L value, which is the number of confirmations of the second contact pattern, to the C value, which is an evaluation value used to determine over- or under-injection.

[0220] Control module 16 can determine over- or under-injection based on the C value. Using again the example from the discussion of step 1642, if the C value is greater than 13, control module 16 can determine that the medical fluid has been under-injected. Alternatively, if the C value is less than 12, control module 16 can determine that the medical fluid has been over-injected.

[0221] Although not shown in FIG. 16, if an over-injection or under-injection is determined, the control module 16 can stop operation of the liquid injection device 10 or notify the user of an alarm to guide them to stop operation of the liquid injection device 10.

[0222] If neither over-injection nor under-injection occurs, proceed to step 1653 .

[0223] In step 1653, control module 16 may reset the number of confirmations L of the second touch pattern to zero and set the number of confirmations H of the first touch pattern to one.

[0224] After step 1653, the process returns to step 1620 again.

[0225] FIG. 17 is a flow chart illustrating a method for determining over- or under-injection of a medical solution when the drive wheel makes one revolution according to one embodiment.

[0226] 17 overlap with steps 1610, 1620, 1630, 1640, 1641, 1650 and 1651 in FIG. 16, and therefore the description of FIG. 17 will be omitted.

[0227] In step 1740, if the current touch pattern is the first touch pattern, control module 16 may determine whether the current touch pattern has changed from the first touch pattern to a second touch pattern.

[0228] If the current touch pattern was changed from a first touch pattern to a second touch pattern, step 1740 proceeds to step 1742 .

[0229] In step 1742, the control module 16 can store the confirmation count H value of the first contact pattern, which is the contact pattern before the change, in a buffer.

[0230] Alternatively, in step 1740, if the current touch pattern is the second touch pattern, control module 16 may determine whether the current touch pattern has changed from the second touch pattern to the first touch pattern.

[0231] If the current touch pattern was changed from the second touch pattern to the first touch pattern, step 1750 proceeds to step 1742 .

[0232] In step 1742, the control module 16 can store the number of confirmations L of the second touch pattern, which is the touch pattern before the change, in a buffer.

[0233] The control module 16 can accumulate and store in a buffer the number of confirmations of the touch pattern before the change until the number of changes in the touch pattern reaches or exceeds a preset number.

[0234] For example, the preset number of times may be the number of times the contact pattern is changed during one rotation of the drive wheel 420. Specifically, the teeth of the drive wheel 420 may move 100 times as the drive wheel 420 rotates once, and four of the protruding steps 420P and four of the tooth steps 933B may be alternately positioned around the drive wheel 420. In this case, the contact pattern changes eight times when the drive wheel 420 rotates once. In this case, the preset number of times may be eight times.

[0235] If the number of times the contact pattern has been changed reaches or exceeds the preset number, the process proceeds to step 1743 .

[0236] In step 1743, the control module 16 may assign the cumulative confirmation count stored in the buffer to a C value, which is an evaluation value used to determine over- or under-injection.

[0237] The control module 16 can determine an over- or under-injection based on the C value. In the example above, if the C value is 101 or greater, the control module 16 can determine that the medical fluid has been under-injected. Alternatively, if the C value is 99 or less, the control module 16 can determine that the medical fluid has been over-injected.

[0238] Although not shown in FIG. 17, if an over-injection or under-injection is determined, the control module 16 can stop operation of the liquid injection device 10 or notify the user of an alarm to guide them to stop operation of the liquid injection device 10.

[0239] If neither over-injection nor under-injection occurs, proceed to step 1744 or step 1745. If the current contact pattern is the first contact pattern, proceed to step 1744, and if the current contact pattern is the second contact pattern, proceed to step 1745.

[0240] In step 1744, control module 16 may reset the number of confirmations H of the first touch pattern to zero and set the number of confirmations L of the second touch pattern to one.

[0241] In step 1745, control module 16 may reset the number of confirmations L of the first touch pattern to zero and set the number of confirmations H of the second touch pattern to one.

[0242] After steps 1744 and 1745, the process returns to step 1720 again.

[0243] Alternatively, the control module 16 may apply different methods to determine whether an under-dosage or over-dosage has occurred.

[0244] For example, the control module 16 can determine under-injection of the medicinal liquid every time the drive module 300 is driven and the teeth of the drive wheel 420 of the drive unit 400 move once. That is, the control module 16 can determine under-injection of the medicinal liquid every time the contact pattern is confirmed. Also, the control module 16 can determine over-injection of the medicinal liquid every time the drive wheel 420 rotates once.

[0245] In particular, the control module 16 can determine that the current contact pattern on the encoder unit 930 is the first contact pattern or the second contact pattern.

[0246] The control module 16 can verify that the current touch pattern is maintained in the first touch pattern or the second touch pattern and calculate the number of verifications.

[0247] In response to a change in the current contact pattern from the first contact pattern to the second contact pattern, or from the second contact pattern to the first contact pattern, the control module 16 may store in a buffer the number of confirmations of the contact pattern before the change.

[0248] The control module 16 can accumulate and store the confirmation count in a buffer until the number of changes in the contact pattern reaches or exceeds a preset number. In response to the number of changes in the contact pattern reaching or exceeding the preset number, the control module 16 can determine an overinjection of the drug solution based on the cumulative confirmation count accumulated in the buffer.

[0249] The control module 16 can determine whether or not the drug solution has been overinjected based on the cumulative confirmation count accumulated in the buffer every time the drive wheel 420 rotates one wheel. The control module 16 can substitute the cumulative confirmation count into a second evaluation value (C2 value) and determine whether or not the drug solution has been overinjected based on the C2 value.

[0250] For example, the preset number of times may be the number of times the contact pattern changes during one rotation of the drive wheel 420. Specifically, the teeth of the drive wheel 420 move 100 times for one rotation of the drive wheel 420, and four of the protruding steps 420P and four of the tooth steps 933B may be alternately positioned around the drive wheel 420. In this case, when the drive wheel 420 rotates one time, the contact pattern changes eight times. In this case, the preset number of times may be eight times. If the C2 value is 99 times or less, the control module 16 may determine that the medicinal liquid has been overinjected. In this case, if the C2 value is 101 times or more, the control module 16 may determine that the medicinal liquid has been underinjected. Alternatively, the determination when the C2 value is 101 times or more may be omitted.

[0251] Furthermore, the control module 16 can determine whether or not there is an underinjection of the liquid medicine based on the sum of the cumulative confirmation count accumulated in the buffer when the number of changes in the contact pattern is "the preset number - 1" and the confirmation count of the current contact pattern. The control module 16 can assign the sum to a first evaluation value (C1 value) and determine whether or not there is an underinjection of the liquid medicine based on the C1 value.

[0252] For example, if the teeth of the drive wheel 420 move 100 times for one rotation of the drive wheel 420, and the contact pattern changes 8 times when the drive wheel 420 rotates one time, the contact pattern corresponds to 12.5 tooth movements. In this case, the preset number of times can be 8 times, and the "preset number of times - 1" can be 7 times. The control module 16 can determine under-injection of the medicinal solution based on the sum of the cumulative confirmation number stored in the buffer while the contact pattern changes 7 times and the confirmation number for the current contact pattern.

[0253] Specifically, since one contact pattern corresponds to 12.5 tooth movements, the teeth can move 87.5 times on average while the contact pattern changes 7 times. That is, when rounding or truncation is applied to the first decimal place, the C1 value can be "87 times + the number of confirmations for the current contact pattern" or "88 times + the number of confirmations for the current contact pattern". Since the teeth of the drive wheel 420 must move 100 times to rotate the drive wheel 420 once, if the C1 value is 101 times or more, the control module 16 can determine that the drug solution has been underinjected. In this case, the determination can be omitted when the C1 value is 99 times or less.

[0254] In a situation where the liquid medicine is underinjected, the movement of the teeth of the drive wheel 420 is delayed, but if the presence or absence of the liquid medicine is determined based on when the drive wheel 420 rotates once or when the connection pattern is changed, the presence or absence of the underinjection can be recognized late. Also, if the movement of the teeth of the drive wheel 420 is interrupted, a situation may occur where the presence or absence of the underinjection cannot be determined. In consideration of this, in the present invention, the presence or absence of the liquid medicine underinjection is determined every time the contact pattern is confirmed, and the presence or absence of the liquid medicine overinjection is determined every time the drive wheel 420 rotates once, thereby solving all of the above problems.

[0255] Various embodiments of the present disclosure may be implemented as software (e.g., a program) including one or more instructions stored in a machine-readable storage medium. For example, a processor of the machine may retrieve and execute at least one instruction of the one or more instructions stored in the storage medium. This allows the machine to operate to perform at least one function according to the retrieved at least one instruction. The one or more instructions may include code generated by a compiler or code that may be executed by an interpreter. The machine-readable storage medium may be provided in the form of a non-transitory storage medium. Here, "non-transitory" simply means that the storage medium is a tangible device and does not include a signal (e.g., electromagnetic wave), and this term does not distinguish between a case where data is semi-permanently stored in the storage medium and a case where data is temporarily stored in the storage medium.

[0256] According to one embodiment, the method according to various embodiments of the present disclosure may be provided in a computer program product. The computer program product may be traded between a seller and a buyer as a commodity. The computer program product may be distributed in the form of a machine-readable storage medium (e.g., compact disc read only memory (CD-ROM)) or may be distributed online (e.g., downloaded or uploaded) via an application store (e.g., Play Store™) or directly between two user devices. In the case of online distribution, at least a part of the computer program product may be at least temporarily stored or temporarily generated in a machine-readable storage medium such as a memory of a manufacturer's server, an application store's server, or an intermediary server.

[0257] Furthermore, in this specification, a "unit" may be a hardware component, such as a processor or a circuit, and / or a software component executed by a hardware component, such as a processor.

[0258] The scope of the present embodiment is indicated by the claims below, rather than the above detailed description, and should be interpreted as including all modifications and variations derived from the meaning and scope of the claims and their equivalent concepts.

[0259] According to an embodiment of the present invention, the liquid medicine injector can be applied to various industrially applicable devices, such as devices for delivering various drugs.

Claims

[Claim 1] A substrate; a needle assembly attached to the base; a reservoir fluidly connected to the needle assembly and having a plunger therein; A drive unit for linearly moving the plunger; an encoder unit disposed at an end of the drive unit for measuring rotation of the drive unit; The encoder unit includes: a base cover attached to an end of the drive unit and rotating together with the drive unit; a first contact end connected to contact one side of the base cover; a second contact end that is disposed on the other side of the base cover and selectively contacts the base cover in response to rotation of the drive unit; The base cover includes: a cover stage extending in a circumferential direction of the rotating drive unit; a plurality of tooth stages extending from the cover stage and spaced apart from one another along a circumferential direction of the cover stage; The drive unit has a protruding step disposed between adjacent tooth steps of the plurality of tooth steps, and a height of the protruding step varies in a radial direction such that the protruding step and the tooth step have a step in a circumferential direction; The protruding step has a first wall and a second wall on one side and the other side, respectively; a height of the first wall is smaller than a height of each of the tooth steps; The height of the second wall is greater than the height of the tooth step, the height of the protruding step increases from the first wall to the second wall; The first contact end and the second contact end have elasticity.

Citation Information

Patent Citations

  • Dispenser Components And Methods For Patient Infusion Device

    US20070073229A1